Skip to content
The Policy VaultThe Policy Vault

Levofloxacin injection — CareFirst (Caremark)

Community-acquired pneumonia (5-day regimen)

Initial criteria

  • Patient age ≥ 18 years
  • Used for treatment of listed infections caused by susceptible isolates of designated microorganisms
  • Intravenous administration is indicated when advantageous to patient (cannot tolerate oral dosage)
  • Use only to treat or prevent infections proven or strongly suspected to be caused by susceptible bacteria
  • Prolonged therapy beyond 28 days in adults or 14 days in pediatric patients only when benefits outweigh risks